Corcept Therapeutics, Inc. (CORT)
42.49
+0.51
(+1.21%)
USD |
NASDAQ |
Apr 02, 16:00
41.88
-0.61
(-1.44%)
After-Hours: 06:27
Corcept Therapeutics EPS Diluted (Quarterly) : 0.1994 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
| Integer Holdings Corp. | 1.383 |
| Ultragenyx Pharmaceutical, Inc. | -1.291 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.90M |
| Revenue (Quarterly) | 202.12M |
| Total Expenses (Quarterly) | 178.22M |
| Enterprise Value | 4.154B |
| Gross Profit Margin (Quarterly) | 98.74% |
| Profit Margin (Quarterly) | 11.83% |
| Earnings Yield | 1.93% |
| Operating Earnings Yield | 0.88% |
| Normalized Earnings Yield | 1.925 |